• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Nar­can mak­er Opi­ant shelves bu­lim­ia pro­gram af­ter mid-stage flop

5 years ago
R&D

Star­board plots board coup af­ter buy­ing in­to Bris­tol-My­ers in lead-up to Cel­gene buy­out vote

5 years ago
Deals

Dear Bernie: Cat­a­lyst CEO McE­nany de­fends his $375,000 price tag on an old drug once of­fered for free

5 years ago
Pharma

Al­lo­gene blue­prints a new man­u­fac­tur­ing com­plex for next-gen CAR-T; In­ovio spins out neoanti­gen up­start with $10.5M A ...

5 years ago
News Briefing

Ra­maswamy's rare-dis­ease off­shoot En­zy­vant poach­es Alex­ion ex­ec Rachelle Jacques to re­place Alvin Shih at the helm

5 years ago
People

Off-the-shelf CAR-T from stem cells? An ear­ly look at UCLA tech — li­censed by Gilead

5 years ago
Discovery

Mer­ck­'s Roger Perl­mut­ter pays $300M to scoop up a bat­tered Im­mune De­sign for its I/O work

5 years ago
Deals

MPM adds $408M for its next big wave of biotech star­tups — and on­col­o­gy still dom­i­nates the menu

5 years ago
Financing

Serono spin­off Ca­lyp­so Biotech be­comes res­i­dent at J&J's Eu­ro­pean in­cu­ba­tor, rais­es $22M+ in Se­ries A

5 years ago
Financing
Startups

J&J steps up along­side Ab­b­Vie to part­ner with fast-grow­ing Mor­phic on its small mol­e­cule ap­proach to in­te­grins

5 years ago
R&D
Pharma

FDA cites an ‘on­go­ing re­view’ for Pfiz­er's block­buster Xel­janz, with im­pli­ca­tions for the class

5 years ago
Pharma

Kalei­do sets terms for $100M IPO; Mallinck­rodt touts pos­i­tive PhI­II GVHD da­ta, cuts tri­al short

5 years ago
News Briefing

Pelo­ton rais­es a mon­ster $150M in lat­est round, as lead drug heads for piv­otal tri­al

5 years ago
Financing

Ap­ply­ing CRISPR to Duchenne, Duke re­searchers spot­light 1-year mouse da­ta in Sarep­ta-spon­sored study

5 years ago
Discovery

IP trou­ble de­fers launch of Novo's long-act­ing he­mo­phil­ia ther­a­py

5 years ago
Pharma

Deaths spur par­tial hold for Xen­cor’s CD3 bis­pe­cif­ic for leukemia, part­nered with No­var­tis in $2.5B deal

5 years ago
R&D

Stem cell ther­a­pies for space mis­sions? Pluris­tem joins forces with NASA to com­bat space-re­lat­ed ail­ments

5 years ago
R&D
Pharma

Backed by Or­biMed and J&J to build pre­ci­sion bac­te­ria-killing tool, Bio­mX adds a slate of in­vestors in $32M Se­ries B

5 years ago
Financing
Startups

Pfiz­er drops 10 mg dose of best-sell­ing Xel­janz as study spot­lights car­dio safe­ty is­sue, high­er rate of deaths

5 years ago
R&D

Mer­ck’s PhI­II liv­er can­cer study for Keytru­da fails on two key end­points, just three months af­ter the FDA gave it ...

5 years ago
R&D

Strike 3: Vi­cal ax­es its on­ly re­main­ing clin­i­cal pro­gram, com­plet­ing a tri­fec­ta of dis­as­ters

5 years ago
R&D

Stock ac­tivists fire back at Al­ler­gan’s de­fen­sive moves, push for a com­pa­ny sale

5 years ago
Deals

FDA cau­tions over young donor blood trans­fu­sions to treat ag­ing, mem­o­ry loss

5 years ago
Pharma

Ab­b­Vie scores speedy re­view for RA drug upadac­i­tinib; Mer­ck KGaA wins CRISPR patent

5 years ago
News Briefing
First page Previous page 697698699700701702703 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2023

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS MARKETING RX Tue at 2 PM ET

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

Healthcare

ENDPOINTS HEALTH TECH Coming soon

Want unlimited access? Sign up for a premium subscription plan.

Endpoints News

Confirm Profile

Endpoints News

Join over 182,300 biopharma colleagues who rely on Endpoints News every business day for the latest developments in drug discovery, development, and commercialization.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS MARKETING RX Tuesday at 2 PM ET

ENDPOINTS FDA+ Wednesday at 2 PM ET

ENDPOINTS MANUFACTURING Thursday at 2 PM ET

ENDPOINTS WEEKLY Saturday at 6 AM ET

Healthcare

ENDPOINTS HEALTH TECH Coming soon

Endpoints News